Covid-19-induced hyperleucocytosis in chronic lymphocytic leukaemia

Balraj Singh; Sarah Ayad; Parminder Kaur; Ro Jay Reid; Sachin Gupta; Michael Maroules

doi:10.12890/2021_002348

Covid-19-induced hyperleucocytosis in chronic lymphocytic leukaemia

Balraj Singh, Sarah Ayad, Parminder Kaur, Ro Jay Reid, Sachin Gupta, Michael Maroules

Department of Medicine

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus responsible for the current global pandemic, coronavirus disease 2019 (COVID-19). COVID-19 usually presents with respiratory symptoms but can affect multiple organ systems. A wide spectrum of complications can occur depending upon the comorbidities of patients. There is limited literature available regarding the presentation and outcome of COVID-19 in chronic lymphocytic leukaemia (CLL) patients. We report 2 cases of COVID-19-induced hyperleucocytosis (WBC count >100,000/μl) in CLL patients.

Original language	English (US)
Journal	European Journal of Case Reports in Internal Medicine
Volume	8
Issue number	3
DOIs	https://doi.org/10.12890/2021_002348
State	Published - 2021

All Science Journal Classification (ASJC) codes

Internal Medicine

Access to Document

10.12890/2021_002348

Cite this

@article{c5855516c07b423f82f7665bfdd94152,

title = "Covid-19-induced hyperleucocytosis in chronic lymphocytic leukaemia",

abstract = "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus responsible for the current global pandemic, coronavirus disease 2019 (COVID-19). COVID-19 usually presents with respiratory symptoms but can affect multiple organ systems. A wide spectrum of complications can occur depending upon the comorbidities of patients. There is limited literature available regarding the presentation and outcome of COVID-19 in chronic lymphocytic leukaemia (CLL) patients. We report 2 cases of COVID-19-induced hyperleucocytosis (WBC count >100,000/μl) in CLL patients.",

author = "Balraj Singh and Sarah Ayad and Parminder Kaur and Reid, {Ro Jay} and Sachin Gupta and Michael Maroules",

year = "2021",

doi = "10.12890/2021_002348",

language = "English (US)",

volume = "8",

journal = "European Journal of Case Reports in Internal Medicine",

issn = "2284-2594",

publisher = "SMC Media Srl",

number = "3",

}

TY - JOUR

T1 - Covid-19-induced hyperleucocytosis in chronic lymphocytic leukaemia

AU - Singh, Balraj

AU - Ayad, Sarah

AU - Kaur, Parminder

AU - Reid, Ro Jay

AU - Gupta, Sachin

AU - Maroules, Michael

PY - 2021

Y1 - 2021

N2 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus responsible for the current global pandemic, coronavirus disease 2019 (COVID-19). COVID-19 usually presents with respiratory symptoms but can affect multiple organ systems. A wide spectrum of complications can occur depending upon the comorbidities of patients. There is limited literature available regarding the presentation and outcome of COVID-19 in chronic lymphocytic leukaemia (CLL) patients. We report 2 cases of COVID-19-induced hyperleucocytosis (WBC count >100,000/μl) in CLL patients.

AB - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus responsible for the current global pandemic, coronavirus disease 2019 (COVID-19). COVID-19 usually presents with respiratory symptoms but can affect multiple organ systems. A wide spectrum of complications can occur depending upon the comorbidities of patients. There is limited literature available regarding the presentation and outcome of COVID-19 in chronic lymphocytic leukaemia (CLL) patients. We report 2 cases of COVID-19-induced hyperleucocytosis (WBC count >100,000/μl) in CLL patients.

UR - http://www.scopus.com/inward/record.url?scp=85147910636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85147910636&partnerID=8YFLogxK

U2 - 10.12890/2021_002348

DO - 10.12890/2021_002348

M3 - Article

AN - SCOPUS:85147910636

SN - 2284-2594

VL - 8

JO - European Journal of Case Reports in Internal Medicine

JF - European Journal of Case Reports in Internal Medicine

IS - 3

ER -

Covid-19-induced hyperleucocytosis in chronic lymphocytic leukaemia

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this